KLK3 and posterior cortical atrophy: In their study, the authors were able to develop a molecular signature predictive of PCa combined with serum PSA in a diagnostic test, which was able to discriminate between benign disease and high- and low-grade tumors, reducing the total number of unnecessary biopsies [104].